Patience David
Transaction: 07/01/2026
SELL
Change
-14,650
Price
$4.46
Filing
07/06/2026
Type
SELL
TriSalus Life Sciences, Inc.
TLSI • Medical - Devices
$5.00
▲ +0.02 (+0.40%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$291.48M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 45.1%Healthy liquidity · 2.8Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.00
Change0.40%
Shares Out58.30M
Market Cap$291.48M
Enterprise Value$279.62M
52W Range2.20 - 7.95
Beta0.43
P/E-10.33
P/S6.47
P/B44.50
P/FCF-9.75
EV/Sales6.20
Price$5.00
Change0.40%
Shares Out58.30M
Market Cap$291.48M
Enterprise Value$279.62M
52W Range2.20 - 7.95
Beta0.43
P/E-10.33
P/S6.47
P/B44.50
P/FCF-9.75
EV/Sales6.20
EV/EBITDA-8.46
EV/FCF-9.35
Earnings Yield-9.68%
FCF Yield-10.26%
Dividend Yield0.00%
Gross Margin84.57%
Oper. Margin-59.68%
Profit Margin-86.88%
Debt/Eq-1.02
Current Ratio2.80
Quick Ratio2.54
Target$8.00
Target Upside60.00%
Target Median$8.00
Target Range8.00 - 8.00
Volume7.81K
Avg Volume470.03K
EPS Surprise-0.17
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Positive revenue growth · 45.1%Healthy liquidity · 2.8Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$8.00
Mean
$8.00
Median
$8.00
High
$8.00
Insider Transactions
Recent executive and insider activity
Marshak Richard
Transaction: 06/30/2026
BUY
Change
+561
Price
$3.87
Filing
07/01/2026
Type
BUY
Szela Mary T
Transaction: 06/30/2026
BUY
Change
+3,990
Price
$3.87
Filing
07/01/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Patience David | SELL | -14,650 | $4.46 | 07/01/2026 | 07/06/2026 |
| Marshak Richard | BUY | +561 | $3.87 | 06/30/2026 | 07/01/2026 |
| Szela Mary T | BUY | +3,990 | $3.87 | 06/30/2026 | 07/01/2026 |
| Marshak Richard | OTHER | 0 | Not reported | 12/31/2025 | 07/01/2026 |
| Szela Mary T | OTHER | 0 | Not reported | 12/31/2025 | 07/01/2026 |
| Marshall Richard Henry | OTHER | 0 | Not reported | 06/29/2026 | 06/29/2026 |
| Marshall Richard Henry | OTHER | +60,000 | $5.55 | 06/29/2026 | 06/29/2026 |
| Marshak Richard | SELL | -543 | $2.67 | 05/15/2026 | 05/19/2026 |
| Gordon Gary B. | BUY | +10,000 | $2.46 | 05/15/2026 | 05/18/2026 |
| Patience David | BUY | +7,100 | $2.43 | 05/15/2026 | 05/18/2026 |
| Szela Mary T | BUY | +39,682 | $2.59 | 05/15/2026 | 05/18/2026 |
| Stansky Michael P | BUY | +200,000 | $2.50 | 05/15/2026 | 05/18/2026 |
| Wahlstrom Mats | BUY | +60,000 | $2.53 | 05/15/2026 | 05/18/2026 |
| Stansky Michael P | BUY | +47,003 | $2.52 | 05/14/2026 | 05/15/2026 |
| Stansky Michael P | BUY | +23,501 | Not reported | 05/14/2026 | 05/15/2026 |
| Valle William | BUY | +28,201 | Not reported | 05/14/2026 | 05/15/2026 |
| Valle William | BUY | +56,403 | $2.52 | 05/14/2026 | 05/15/2026 |
| MATLIN DAVID J | BUY | +56,403 | $2.52 | 05/14/2026 | 05/15/2026 |
| MATLIN DAVID J | BUY | +28,201 | Not reported | 05/14/2026 | 05/15/2026 |
| Gordon Gary B. | BUY | +28,201 | Not reported | 05/14/2026 | 05/15/2026 |